Literature DB >> 8204591

The fibrin(ogen)olytic properties of cathepsin D.

D I Simon1, A M Ezratty, J Loscalzo.   

Abstract

Fibrin(ogen) is important for hemostasis and is cleared from sites of vascular injury primarily by the plasminogen activator system. However, there is emerging evidence in plasminogen activator-deficient transgenic mice that non-plasmin pathways may also be important for endogenous fibrinolysis. We have recently described an alternative, plasmin-independent fibrinolytic pathway in activated human monocytes that utilizes the integrin Mac-1 (CD11b/CD18), which directly binds and internalizes fibrin, resulting in its lysosomal degradation. The identity of the lysosomal fibrinolytic enzyme(s) responsible for monocyte/macrophage-mediated fibrinolytic is unknown. Protease inhibitor studies now suggest that an aspartyl protease is responsible for this fibrinolytic activity. We, therefore, examined the fibrinolytic properties of cathepsin D, a lysosomal aspartyl protease, and report that cathepsin D possesses both fibrinogenolytic and fibrinolytic activity. Cathepsin D cleavage of fibrinogen follows Michaelis-Menten kinetics with a Michaelis constant, Km, of 1.5 microM; catalytic rate constant, kcat, of 1.4 x 10(-3) s-1; and catalytic efficiency, kcat/Km, of 9.3 x 10(-4) microM-1 s-1. A pH-activity profile of fibrinogen digestion by cathepsin D demonstrates a pH optimum of 3.5 with 50% residual activity at pH 5.0. Fibrinolysis was assessed by fibrin plate and fibrin clot lysis assays. Cathepsin D possesses significant fibrinolytic activity over a dose range of 100 nM to 10 microM and is able to lyse fibrin, as well as albumin-enriched and albumin/red cell-enriched fibrin clots. Cathepsin D cleaves the alpha-, beta-, and gamma-chains of FGN, generating multiple low-molecular-weight fragments.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8204591     DOI: 10.1021/bi00187a024

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  9 in total

1.  Computational predictions of cysteine cathepsin-mediated fibrinogen proteolysis.

Authors:  Meghan C Ferrall-Fairbanks; Dayne M West; Simone A Douglas; Rodney D Averett; Manu O Platt
Journal:  Protein Sci       Date:  2017-12-28       Impact factor: 6.725

2.  Kinetics of low-density lipoprotein receptor activity in Hep-G2 cells: derivation and validation of a Briggs-Haldane-based kinetic model for evaluating receptor-mediated endocytotic processes in which receptors recycle.

Authors:  H J Harwood; L D Pellarin
Journal:  Biochem J       Date:  1997-05-01       Impact factor: 3.857

3.  A mAb to the beta2-leukocyte integrin Mac-1 (CD11b/CD18) reduces intimal thickening after angioplasty or stent implantation in rabbits.

Authors:  C Rogers; E R Edelman; D I Simon
Journal:  Proc Natl Acad Sci U S A       Date:  1998-08-18       Impact factor: 11.205

4.  Polynitrosylated proteins: characterization, bioactivity, and functional consequences.

Authors:  D I Simon; M E Mullins; L Jia; B Gaston; D J Singel; J S Stamler
Journal:  Proc Natl Acad Sci U S A       Date:  1996-05-14       Impact factor: 11.205

5.  Lysosomal processing of amyloid precursor protein to A beta peptides: a distinct role for cathepsin S.

Authors:  J S Munger; C Haass; C A Lemere; G P Shi; W S Wong; D B Teplow; D J Selkoe; H A Chapman
Journal:  Biochem J       Date:  1995-10-01       Impact factor: 3.857

Review 6.  Cathepsin D--many functions of one aspartic protease.

Authors:  Petr Benes; Vaclav Vetvicka; Martin Fusek
Journal:  Crit Rev Oncol Hematol       Date:  2008-04-08       Impact factor: 6.312

Review 7.  Cathepsin D expression levels in nongynecological solid tumors: clinical and therapeutic implications.

Authors:  Gaetano Leto; Francesca M Tumminello; Marilena Crescimanno; Carla Flandina; Nicola Gebbia
Journal:  Clin Exp Metastasis       Date:  2004       Impact factor: 5.150

8.  Elevated levels of fibrinogen-derived endogenous citrullinated peptides in synovial fluid of rheumatoid arthritis patients.

Authors:  Reinout Raijmakers; Joyce J B C van Beers; Mahmoud El-Azzouny; Natasja F C Visser; Borut Božič; Ger J M Pruijn; Albert J R Heck
Journal:  Arthritis Res Ther       Date:  2012-05-14       Impact factor: 5.156

9.  Total Syntheses of Cathepsin D Inhibitory Izenamides A, B, and C and Structural Confirmation of Izenamide B.

Authors:  Changjin Lim
Journal:  Molecules       Date:  2019-09-20       Impact factor: 4.411

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.